Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues, which decreases over time.

The preferred sleeping position may be a modifiable risk factor for keratoconus asymmetry in the dependent eye, a study suggests.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

The FDA is adopting a new regulatory framework that will change the criteria for approval of COVID-19 vaccines.

An electric injury can cause various types of ocular damage, primarily within the lens or retina, a large systemic review reports.

As of today, the total measles case count in the United States is 1,088, according to the US Centers for Disease Control and Prevention.

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine — causing sharp criticism from doctors and other experts.

The prevalence of disability among adults who currently smoke cigarettes is more than twofold higher than that seen for never smokers.

An evidence-based treatment protocol can improve outcomes in patients with Acanthamoeba keratitis, a study shows.

Treatment delays for patients with glaucoma during the COVID-19 pandemic were more pronounced in women and patients with advanced age.

Slower tapering of adalimumab (ADA) significantly reduces the risk for noninfectious uveitis (NIU) relapse among pediatric patients, particularly those with juvenile idiopathic arthritis ...

The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.